Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Vaccines |
Free Subscription
1 Arch Virol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Vaccines is free of charge.
Complete genome sequence of vaccinium-associated virus C, a new member of the
family Totiviridae from Vaccinium floribundum.
Arch Virol. 2024;169:86.
PubMed
Abstract available
Unusual presentation of miliary tuberculosis in a 12-year-old girl: a case
report.
BMC Pediatr. 2024;24:223.
PubMed
Abstract available
After years of decline, Brazil sees vaccination coverage rise in 2023.
BMJ. 2024;385:q668.
PubMed
Measles: South Sudan reports 12 000 cases in three months.
BMJ. 2024;384:q777.
PubMed
Investigation of an mpox outbreak affecting many vaccinated persons in Chicago,
IL-March 2023-June 2023.
Clin Infect Dis. 2024 Apr 3:ciae181. doi: 10.1093.
PubMed
Abstract available
Optimization of Mother-to-Child Hepatitis B Virus Prevention Program: Integration
of Maternal Screening and Infant Post-vaccination Serologic Testing.
Clin Infect Dis. 2024 Apr 2:ciae176. doi: 10.1093.
PubMed
Abstract available
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision
model to predict bacterial aetiology.
J Infect. 2024 Mar 27:106145. doi: 10.1016/j.jinf.2024.106145.
PubMed
Abstract available
Resurgence and atypical patterns of pertussis in China.
J Infect. 2024;88:106140.
PubMed
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or
frailty: the RAVEN cohort study.
J Infect. 2024 Feb 29:106129. doi: 10.1016/j.jinf.2024.106129.
PubMed
Abstract available
Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in
adults successfully treated for drug-susceptible pulmonary TB: a phase 1
randomized trial.
J Infect Dis. 2024 Apr 1:jiae170. doi: 10.1093.
PubMed
Abstract available
Medical Costs of RSV-associated Hospitalizations and Emergency Department Visits
in Children Aged <5 years: Observational Findings from the New Vaccine
Surveillance Network (NVSN), 2016-2019.
J Pediatr. 2024 Mar 30:114045. doi: 10.1016/j.jpeds.2024.114045.
PubMed
Abstract available
Cynomolgus macaques as a translational model of human immune responses to yellow
fever 17D vaccination.
J Virol. 2024 Apr 3:e0151623. doi: 10.1128/jvi.01516.
PubMed
Abstract available
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2
spike protein brought to phase I/II clinical trials: candidate selection in a
preclinical murine model.
J Virol. 2024 Apr 2:e0169323. doi: 10.1128/jvi.01693.
PubMed
Abstract available
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2
spike protein brought to phase I/II clinical trials: protection of African green
monkeys from COVID-19 disease.
J Virol. 2024 Apr 2:e0176223. doi: 10.1128/jvi.01762.
PubMed
Abstract available
CDC Recommends Additional COVID-19 Booster for Older Adults.
JAMA. 2024 Mar 13. doi: 10.1001/jama.2024.2071.
PubMed
Bivalent conjugate vaccines for typhoid and paratyphoid fever.
Lancet. 2024 Mar 28:S0140-6736(24)00461-6. doi: 10.1016/S0140-6736(24)00461.
PubMed
The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella
enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised,
active-controlled, double-blind trial.
Lancet. 2024 Mar 28:S0140-6736(24)00249-6. doi: 10.1016/S0140-6736(24)00249.
PubMed
Abstract available
Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19
Vaccinations Across Sociodemographic Characteristics - United States, September
1, 2022-September 30, 2023.
MMWR Morb Mortal Wkly Rep. 2024;73:286-290.
PubMed
Abstract available
Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain
Reaction Panels - United States, May 2022-April 2023.
MMWR Morb Mortal Wkly Rep. 2024;73:260-264.
PubMed
Abstract available
Systematic testing in cholera surveillance enhances vaccine impact and
cost-effectiveness.
Nat Med. 2024 Apr 3. doi: 10.1038/s41591-024-02907.
PubMed
Post-campaign coverage evaluation of a measles and rubella supplementary
immunization activity in five districts in India, 2019-2020.
PLoS One. 2024;19:e0297385.
PubMed
Abstract available
Clinical and economic burden of acute otitis media caused by Streptococcus
pneumoniae in European children, after widespread use of PCVs-A systematic
literature review of published evidence.
PLoS One. 2024;19:e0297098.
PubMed
Abstract available
Determinants of health as predictors for differential antibody responses
following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal
cohort.
PLoS One. 2024;19:e0292566.
PubMed
Abstract available
Post-vaccination SARS-CoV-2 IgG spike antibody responses among clinical and
non-clinical healthcare workers at a tertiary facility in Kenya.
PLoS One. 2024;19:e0299302.
PubMed
Abstract available
Neutralizing antibody responses to the Delta variant of SARS-CoV-2 following
vaccination with Ad5-nCoV (CanSino) in the Mexican population.
PLoS One. 2024;19:e0299520.
PubMed
Abstract available
Comparative study on alginate/chitosan microcapsules and Montanide ISA 61 as
vaccine adjuvants in mice.
PLoS One. 2024;19:e0298117.
PubMed
Abstract available
Impact of immune evasion, waning and boosting on dynamics of population mixing
between a vaccinated majority and unvaccinated minority.
PLoS One. 2024;19:e0297093.
PubMed
Abstract available
Spatial variations and determinants of timely completion of vaccination in
Ethiopia using further analysis of EDHS 2019 data: Spatial and multilevel
analysis.
PLoS One. 2024;19:e0301409.
PubMed
Abstract available
Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against
COVID-19-associated hospitalisation and death in the Seychelles infected adult
population.
PLoS One. 2024;19:e0299747.
PubMed
Abstract available
Review of mathematical models of Neisseria gonorrhoeae vaccine impact:
Implications for vaccine development.
Vaccine. 2024 Mar 30:S0264-410X(24)00380-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Testing the impact of differing behavioural science informed text message content
in COVID-19 vaccination invitations on vaccine uptake: A randomised clinical
trial.
Vaccine. 2024 Mar 28:S0264-410X(24)00365-7. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Effectiveness of COVID-19 vaccination against school absenteeism in children and
adolescents hospitalized with COVID-19.
Vaccine. 2024 Mar 30:S0264-410X(24)00397-9. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Self-reported determinants of COVID-19 vaccine acceptance among persons with and
without autoimmune disease.
Vaccine. 2024 Mar 30:S0264-410X(24)00373-6. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Perceptions, attitudes, and willingness of healthcare and frontline workers to
participate in an Ebola vaccine trial in Uganda.
Vaccine. 2024 Apr 1:S0264-410X(24)00358-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum
and mucosal antibody responses with experimental Streptococcus pneumoniae
serotype 6B colonisation.
Vaccine. 2024 Apr 2:S0264-410X(24)00360-8. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine
(IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3,
randomized, active-controlled, multicenter trial.
Vaccine. 2024 Apr 3:S0264-410X(24)00399-2. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Identifying effective vaccine champions: Findings from a national survey of
primary care professionals.
Vaccine. 2024 Apr 3:S0264-410X(24)00403-1. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal
conjugate vaccine in US adults aged 50 years or older.
Vaccine. 2024 Apr 4:S0264-410X(24)00404-3. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following
concomitant COVID-19 and influenza vaccination in the ComFluCOV trial.
Vaccine. 2024 Apr 4:S0264-410X(24)00367-0. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
A comparison of four self-controlled study designs in an analysis of COVID-19
vaccines and myocarditis using five European databases.
Vaccine. 2024 Apr 5:S0264-410X(24)00330-X. doi: 10.1016/j.vaccine.2024.
PubMed
Abstract available
Thank you for your interest in scientific medicine.